Cantor: Relypsa Sale Makes Sense

By: via Benzinga
Analysts at Cantor said the potential sale of Relypsa Inc (NASDAQ: RLYP) makes sense. Earlier, Reuters reported the biopharma company ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.